ALKS Q4 2017 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$275M+29.0% YoY

Gross Profit

$237M86.0% margin

Operating Income

$6M2.1% margin

Net Income

-$10M-3.6% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+26.7%

Cash Flow

Operating Cash Flow

$36M

Free Cash Flow

$18M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$594M

Stockholders' Equity

$1.2B

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$275M	$214M	+29.0%
Gross Profit	$237M	$179M	+32.7%
Operating Income	$6M	-$24M	+124.8%
Net Income	-$10M	-$21M	+53.7%